Abstract
Abstract We give a Bayesian analysis of the group sequential clinical trial to compare an experimental treatment with the standard treatment. Survival time is modelled as exponential. The trial is monitored at specified time points, either after fixed time intervals or after a fixed number of failures. The group sequential trial may consequently be modelled as a straightforward sequential trial in which survival time is the sum of exponential random variables, that is it has a gamma distribution. We use Bayes sequential decision theory to analyse the trial. The feature of this which is technically demanding is the need, after each observation, to look forward to see whether or not to continue sampling or to stop and make a terminal decision. This typically requires the nested sequence of integrations and minimisations. We provide two approximations: firstly taking the logarithm ofthe gamma random variable as normal; secondly making a reduction to logrank statistics. Monte Carlo simulations show both approximations to be comparable with respect to frequentist and Bayesian characteristics and to have good robustness with respect to prior specifications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.